Highest-materiality recent filing
ParkerVision reports Q1 net loss $1.6M; Qualcomm appeal oral arguments June 1
Net loss of $1.6M ($0.01/share) for Q1 2026 vs. $3.8M loss a year ago; decrease driven by $2.1M fair value adjustment on contingent obligations.
ParkerVision reports $7.4M net loss; Qualcomm appeal expedited, MediaTek trial postponed
Net loss of $7.4M ($0.06/share) vs. $14.5M loss in 2024; improvement driven by $0.6M gain on contingent payment obligations.
ParkerVision exchanges $688K in notes+interest for 3.28M shares at $0.21/share
Aggregate outstanding principal of $675,000 and accrued interest of $13,200 exchanged for 3,277,099 common shares.
ParkerVision closes $3.46M registered direct offering of 16.5M shares at $0.21/share
Sold 16,481,579 shares at $0.21 each for gross proceeds of ~$3.46M to accredited and institutional investors.
ParkerVision Raises $3.46M in Registered Direct Offering of 16.48M Shares
Sold 16,481,579 shares at $0.21 per share, generating ~$3.46M in aggregate proceeds.
ParkerVision reports Q3 2025 net loss of $2.0M; updates on Qualcomm appeal and upcoming trials
Net loss $2.0M ($0.02/share) in Q3 2025 vs $10.8M ($0.12/share) in Q3 2024; improvement from lower fair-value loss on contingent payment obligations.
ParkerVision Q2 net loss $1.6M; patent litigation updates on Qualcomm, Realtek, MediaTek
Net loss $1.6M for Q2 2025 ($0.01/share) vs $0.3M loss in Q2 2024; H1 2025 loss $5.4M ($0.05/share).
ParkerVision Q1 net loss widens to $3.8M; litigation updates on Qualcomm & Texas cases
Net loss of $3.8M ($0.03/share) vs $0.7M loss in Q3 2024; increase largely due to $2.5M non-cash fair value adjustment.
ParkerVision reports 2024 net loss of $14.5M; patent case against Qualcomm remanded for trial
Net loss of $14.5M ($0.16 loss per share) vs net income of $9.5M ($0.11 EPS) in 2023.
ParkerVision awards CEO $350K, CFO $100K one-time bonuses for strategic contributions
CEO Jeffrey Parker received $350K and CFO Cynthia French $100K in one-time discretionary cash bonuses on Jan 15, 2025.
ParkerVision raises $5M through private placement of 10M shares and 2M warrants at $0.50/share
Raised $5M aggregate proceeds from sale of 10,000,000 shares and 2,000,000 warrants at $0.50/share.
ParkerVision wins CAFC appeal; Qualcomm patent case remanded for trial in Florida
CAFC reversed district court's Daubert exclusion of expert testimony, reinstating infringement claims.
ParkerVision Q2 net loss $0.3M vs year-ago net income; patent litigation updates
Net loss of $0.3M ($0.00 per share) for Q2 2024 vs net income of $1.4M ($0.02) in Q2 2023.
ParkerVision Q1 net loss $0.7M; patent trials set for Dec 2024, Jan 2025
Net loss $0.7M ($0.01/share) vs net income $13.1M ($0.16/share) in Q1 2023, which included a $25M patent settlement.
ParkerVision reports 2023 net income of $9.5M vs loss of $9.8M in 2022; patent trial dates set
Net income $9.5M (EPS $0.11 basic, $0.08 diluted) vs net loss $9.8M in 2022.
ParkerVision reports $10.6M net income for 9 months; Q3 loss $3.9M; patent case updates
Net income of $10.6M ($0.12/share) for nine months ended Sep 30, 2023, vs net loss of $4.5M prior year.
ParkerVision posts $14.5M net income in H1 2023 on $25M patent license deal
Q2 2023 net income of $1.4M ($0.02/share) vs. Q2 2022 net loss of $4.4M ($0.06/share).
ParkerVision posts Q1 net income of $13.1M on $25M patent license revenue
Revenue of $25M from patent license/settlement agreements; net income $13.1M ($0.16/share) vs $0.3M ($0.00) YoY.
ParkerVision reports narrowed 2022 loss and $25M patent settlement in Q1 2023
Net loss for 2022 was $9.8M ($0.13/share), improved from $12.3M ($0.17/share) in 2021.
ParkerVision enters patent license and settlement agreement, expects $25M payment
On February 7, 2023, ParkerVision entered into a patent license and settlement agreement with a third-party.
ParkerVision settles patent litigation with Hisense; terms confidential
Patent license and settlement agreement with Hisense; litigation dismissed and IPR withdrawn.
On May 19, 2026, the Board unanimously appointed Anthony Bowers to fill the director vacancy created by Mr. Titterton’s resignation.
On May 15, 2026, Mr. Lewis Titterton resigned from the Board of Directors (the “Board”) of ParkerVision, Inc. (the "Company"), and from the Audit and Compensation Committees on which he served.
On April 15, 2025, Mr. Sanford Litvack resigned from our Board of Directors, and from the Audit and Compensation Committees on which he served.
Effective June 22, 2023, the Board of Directors of the Company appointed Lewis H. Titterton to fill a Class II director vacancy.
Effective the same date, the Board appointed Sanford M. Litvack to fill the newly created vacancy on the Company’s board of directors.
Max materiality 0.90 · Median 0.55 · Most common event other_material